Nuvation Bio, Inc. (NUVB)
7.91
-0.09
(-1.12%)
USD |
NYSE |
Dec 10, 11:53
Nuvation Bio Total Assets (Quarterly): 601.56M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 208.73B |
| KalVista Pharmaceuticals, Inc. | 339.93M |
| Rapid Micro Biosystems, Inc. | 84.41M |
| ARS Pharmaceuticals, Inc. | 372.80M |
| CEL-SCI Corp. | 20.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 275.68M |
| Shareholders Equity (Quarterly) | 325.88M |
| Debt to Equity Ratio | 0.6387 |
| Current Ratio | 8.477 |
| Net Debt Paydown Yield | 1.28% |